miércoles, 14 de abril de 2021

NIH Trial of Anti-CD14 Antibody to Treat COVID-19 Respiratory Disease Begins | NIH: National Institute of Allergy and Infectious Diseases

NIH Trial of Anti-CD14 Antibody to Treat COVID-19 Respiratory Disease Begins | NIH: National Institute of Allergy and Infectious Diseases

No hay comentarios:

Publicar un comentario